Laboratory Assessment of Pilairo Q CPAP Mask Performance and Ease of Use.
NCT ID: NCT02121912
Last Updated: 2019-06-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2014-06-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilairo Lab Market Research
NCT01824979
The Evaluation of a New Nasal Mask for the Treatment of Obstructive Sleep Apnea
NCT04011826
The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea
NCT03142438
The Evaluation of a Novel Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
NCT03605485
The Evaluation of a Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ
NCT02741635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Only those participants whom are previously diagnosed with an AHI \>5 can be approached and enrolled into the study.
Once the consent form has been signed, participants will be randomly assigned to receive either Pilairo or any other standard care nasal/nasal pillows mask for their CPAP titration. A randomisation log will be provided by FPH.
The titration session will take place as per the lab's routine practice.
Throughout the night the Sleep Technician will record in the CRF the absolute leak value for the mask every 10 minutes.
At the end of the session the Sleep Technician will complete a questionnaire in relation to the titration experience for that participant/mask. The data will be collected in the CRF that FPH staff will provide to the site.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FPH Pilairo Q CPAP mask
The Sleep Technician will fit the FPH Pilairo Q CPAP mask to the participant.
FPH Pilairo Q CPAP mask
CPAP nasal-pillow mask
Any other market released nasal or nasal-pillow CPAP mask
The Sleep Technologist will fit the participant with any market released nasal or nasal-pillow CPAP mask
Any other market released nasal or nasal-pillow CPAP mask
Any other market released nasal or nasal-pillow CPAP mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FPH Pilairo Q CPAP mask
CPAP nasal-pillow mask
Any other market released nasal or nasal-pillow CPAP mask
Any other market released nasal or nasal-pillow CPAP mask
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Equal or greater than 18 years of age
Exclusion Criteria
* History of intolerance to CPAP.
* Anatomical or physiological conditions making CPAP therapy appropriate (for example a deviated septum)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martina Neddermann, Dr.med
Role: PRINCIPAL_INVESTIGATOR
Evangelisches Krankenhaus Herne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evangelisches Krankenhaus Herne
Herne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIA-89
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.